CommercialCoverageLow impact
Macular/Foveal Translocation (CPB 0409, reviewed 2026-07-06)
Aetna·Ophthalmology·Medical Policy
Effective date
Jul 6, 2026
We identified it
Aug 17, 2026
Summary
Aetna has reaffirmed that macular/foveal translocation remains experimental, investigational, or unproven for age-related macular degeneration (AMD) and all other indications. This procedure is not covered by Aetna. No specific CPT or HCPCS codes exist for this procedure, and ICD-10 codes related to AMD and retinal neovascularization are not covered.
Action Required
Effective immediately for Aetna plans: Billing team must ensure that any claims submitted for macular/foveal translocation procedures are denied as non-covered/experimental. Flag any encounter forms or surgical scheduling requests for this procedure and alert providers that Aetna will not reimburse. This is a reaffirmation of long-standing policy (CPB 0409), not a new restriction. No claim processing changes required unless your practice has previously billed for this procedure. If you have existing macular translocation cases pending, contact Aetna directly to notify members of non-coverage status.